Pharmacom Labs Official Approved Dealer | Global Fast Tracked Shipping 
  • New

Matrixyl 3000 10mg

£24.90
No tax

Matrixyl 3000 is a defined synthetic lipopeptide complex developed for experimental investigation of extracellular matrix–associated signalling, peptide–cell interactions, and gene expression pathways related to collagen and matrix protein regulation in cellular research systems.

  • Batch tested Purity: ≥ 99 % (HPLC)
  • CAS Number: 214047-00-4
  • Peptide Type: Synthetic palmitoylated peptide complex

Quantity

redeem
By buying this product you can collect up to 24 loyalty points . Your cart will contain total 24 points that can be converted into a voucher of £0.36 .


Synonyms / Designations: Matrixyl, Palmitoyl Pentapeptide-4, Palmitoyl-KTTKS, PAL-Lys-Thr-Thr-Lys-Ser, Palmitoyl Pentapeptide-3
CAS Number: 214047-00-4
Molecular Formula: C39H75N7O10
Molar Mass: ~802.05 g/mol
Peptide Classification: Synthetic palmitoylated pentapeptide (matrikine-class research peptide)
Purity: ≥ 99 % (HPLC, typical)
Appearance: White to off-white lyophilised powder
Storage: Desiccated, protected from light, stored at –20 °C
Solubility: Soluble in DMSO; limited solubility in water or dilute aqueous buffers depending on formulation

Description & Mechanism

Matrixyl consists of a short pentapeptide sequence covalently modified at the N-terminus with a palmitoyl fatty acid chain. This lipid conjugation increases hydrophobicity and is used in research settings to study peptide–lipid interactions, peptide stability, and extracellular matrix–associated signalling processes in cellular and formulation-based systems.

In experimental models, Matrixyl is utilised as a reference compound for investigating matrikine-related signalling, peptide uptake dynamics, and the behaviour of lipid-modified peptides in dermal or fibroblast-associated research assays. Observed molecular responses are dependent on experimental design, concentration, formulation matrix, and model system.

Applications in Research

  • As a model peptide for studying extracellular matrix–related signalling pathways
  • Investigation of lipid-conjugated peptide stability and behaviour in cellular systems
  • In vitro studies examining peptide–cell and peptide–matrix interactions
  • Reference compound in formulation, compatibility, and peptide delivery research

Handling, Reconstitution & Stability

  • Reconstitute shortly before use in DMSO, dilute acid, or suitable buffer depending on assay requirements
  • Avoid vigorous agitation during dissolution
  • Aliquot reconstituted solutions to minimise repeated freeze–thaw cycles
  • Store reconstituted peptide at 4 °C for short-term use; –20 °C or below for long-term storage
  • Protect from moisture, strong oxidisers, extreme pH, and elevated temperatures

Specifications Summary

Purity: ≥ 99 % (HPLC)
Appearance: White to off-white lyophilised powder
Peptide Length: 5 amino acids plus palmitoyl moiety
Molecular Weight: ~802.05 g/mol
CAS: 214047-00-4
Storage: –20 °C, desiccated, dark

Precautions & Notes

  • Experimental behaviour of Matrixyl is influenced by formulation matrix, concentration, and model system
  • Lipid-modified peptides may exhibit different stability and solubility profiles than non-conjugated peptides
  • Buffer composition and solvent choice can significantly affect assay performance
  • Intended strictly for laboratory research use; not for human or veterinary application

Product Review

Average rating

0.0
0 Review
Excellent 0
Good 0
Medium 0
Poor 0
Terrible 0

  • Reviews (0)
@COMMENT_AVATAR@

@CUSTOMER_NAME@

@AUTHOR_PROFILE@ @COMMENT_ISO_COUNTRY@
@VERIFY_PURCHASE@
(@COMMENT_GRADE@)
@COMMENT_DATE@
@COMMENT_NO_APPROVE@

@COMMENT_TITLE@

@COMMENT_COMMENT@

@COMMENT_IMAGES@
@COMMENT_VIDEOS@
Write a comment
@COMMENT_AVATAR@

@CUSTOMER_NAME@

@AUTHOR_PROFILE@ @COMMENT_ISO_COUNTRY@
@VERIFY_PURCHASE@
@COMMENT_DATE@
@COMMENT_NO_APPROVE@

@COMMENT_COMMENT@

Reply
@COMMENT_AVATAR@

@CUSTOMER_NAME@

@AUTHOR_PROFILE@ @COMMENT_ISO_COUNTRY@
@VERIFY_PURCHASE@
@COMMENT_DATE@
@COMMENT_NO_APPROVE@

@COMMENT_COMMENT@

Reply